04 June 2021: Original Paper
Coronavirus Disease 2019 and Kidney Transplantation in Saudi Arabia: Outcomes and Future Opportunities
Ali Alshaqaq 1ABCDEF* , Abdulnaser Al Abadi 1ACF , Abdulrahman Altheaby 2ABF , Mohammed A. Bukhari 3ABF , Basil Nasrallah 1AB , Alaa Alamoudi 4AB , Ziad Arabi 2A , Fayez Alhejaili 2B , Khalid Bin Saad 2A , Ahmed Busbaih 5B , Mohammed Abdelrahim Idris 1AB , Sumayah Askandarani 1AB , Meteb M. AlBugami 1A , Fahad E. Alotaibi 1E , Khaled Hamawi 1E , Khalid Bel’eed Akkari 1ACEDOI: 10.12659/AOT.931832
Ann Transplant 2021; 26:e931832
Table 2 Clinical presentation and initial investigations.
| Factors | Results (n=130)* |
|---|---|
| Fatigue | 81 (62.3%) |
| Fever | 78 (60%) |
| Cough | 75 (57.7%) |
| Shortness of breath | 38 (29.2%) |
| Diarrhea | 33 (25.4%) |
| Nausea/vomiting | 29 (22.3%) |
| Headache | 27 (20.8%) |
| Alteration in taste or smell | 25 (19.2%) |
| Abnormal chest X-ray | 43 (33.1%) |
| White blood cell count ×10/La | 5.75±2.39 |
| Absolute lymphocyte count | 1.22±0.88 |
| Creatinine at presentation (μmol/L)** | 99 (79–131.5) |
| Procalcitonin (ng/mL)c | 0.24 (0.13–0.79) |
| C-reactive protein (mg/L)d | 40.4 (15.4–80) |
| D-dimer (μg/L)e | 1.05 (0.59–1.4) |
| * Results are expressed as mean±standard deviation, median (25–75 percentile) and number (percentage); ** patients with graft failure were excluded. a White blood cell count (normal range 4.5–11×10/L); b creatinine (normal range 62–115 μmol/L); c procalcitonin (normal range 0–0.1 ng/mL); d C-reactive protein (normal range 0–5 mg/L); e D-dimer (normal range 0–0.55 μg/L). | |